Evidence map›Paper›PMID 37089349›Full record

ArticleHeliyon2023

Remediation and immobilization of Cr(VI)-contaminated soil using stabilized nanoscale iron sulfide and ecological impact.

Sutanu Maiti, Sudarsan Neogi, Binay K Dutta

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 14 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sutanu MaitiIndian Institute of Technology Kharagpur, Kharagpur, 721302, West Bengal, India.
Sudarsan NeogiIndian Institute of Technology Kharagpur, Kharagpur, 721302, West Bengal, India.
Binay K DuttaIndian Institute of Technology Kharagpur, Kharagpur, 721302, West Bengal, India.
Indian Institute of Technology Kharagpur · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Soil contaminated with hexavalent chromium seriously threatens the environment and human health. The use of FeS, which has a high redox activity and excellent reduction capacity, limits its application in soil remediation due to its premature surface oxidation and massive aggregation. To prevent premature surface oxidation and agglomeration, cetyltrimethylammonium bromide-supported nano-ferrous sulfide (CTAB-nFeS) was chemically synthesized and used for immobilizing Cr(VI) in contaminated soil. In order to evaluate the role of CTAB stabilization of nFeS and interaction mechanisms were investigated by XPS, FTIR, XRD, and FESEM. Batch experiments showed a complete reduction of Cr(VI) within 3 h with only 235% excess of CTAB-nFeS at a soil pH of 8 compared to days as reported in the literature with alternative FeS forms. The reduction kinetic data could be satisfactorily fitted into the second-order rate model. The rate constant linearly depends on the soil-to-water ratio, but its logarithmic form is linear in the given pH range. The oxidation-reduction potential increases with decreasing initial pH, thus positively impacting the reduction process. XPS analysis revealed the reduction process as multi-steps (reduction, adsorption, and co-precipitation). Ecological studies showed improved plant growth and earthworm survival rate in the remediated soil. Medium-term stability experiments suggested a significant decrease in TCLP leachate concentration of Cr after CTAB-nFeS treatment and remained stable for 60 d. Overall results of our study suggested a sustainable, feasible, and effective strategy for in-situ remediation of Cr(VI)-contaminated soil using CTAB-nFeS at natural pH.

Indexed as

Cr(VI) immobilization in soilCr(VI)-remediation in soilCTAB-nanoFeSFeS nanoparticlesTCLP of Cr in soil

Identifiers

PMID37089349
PMCPMC10119562
OpenAlexW4361282545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.